openPR Logo
Press release

Neuroprotective Products Market Status and Ongoing Development Trends by Key Players: Genervon Biopharmaceuticals, NeuroVive Pharmaceutical,Ceregene, BHRPharma LLC, Neuren Pharmaceuticals and More

02-22-2019 09:30 AM CET | Health & Medicine

Press release from: Allied Market Research

Neuroprotective Products Market

Neuroprotective Products Market

Neuroprotective products are medications that protect the brain neurons from degeneration and injury. These products are used in the treatment of several central nervous system complications such as Parkinson's disease, Alzheimer's disease, and traumatic brain injuries among others.

Neurodegenerative diseases and their prevalence increases significantly with age. Hence, the demand for neuroprotectives would increase in the future, as average life spans are increasing, which opens up a huge market for novel drugs for the treatment of these diseases.

Competitive Analysis

Genervon Biopharmaceuticals, NeuroVive Pharmaceutical,Ceregene, BHRPharma LLC, Neuren Pharmaceuticals, Allon therapeutics, Inc., Bionure Inc. are some of the key players in this market. In 2013, Bionure and The Myelin Repair Foundation (MRF) entered into a collaborative partnership agreement with the aim of advancing development of therapeutics for multiple sclerosis. This partnership would enable the commercialization of many promising compounds for the treatment of multiple sclerosis.

Get Sample PDF Brochure of Neuroprotective Products Market Study at: https://www.alliedmarketresearch.com/request-toc-and-sample/262

The drivers for this market are the increasing incidence and prevalence of neurodegenerative diseases, especially in aging populations and a need for the treatment of brain injuries caused chiefly by road accidents. However, high costs involved in research and development, strict regulatory approvals and the high failure rate of majority of the prospective drugs in clinical trials would restrict growth in this market. With the high prevalence rates of neurogenerative disease and the lack of specific treatment options, the opportunities are tremendous for the entry of novel drugs.

Neuroprotective Products Market by Class of Drugs

The neuroprotective drugs are Cholinesterase inhibitors, NMDA receptor antagonists, Ion channel modulators, Anti-inflammatory and anti-apoptotic agents, Mitochondrial dysfunction regulators Neurotropic factors, Anti excitotoxic agents , Ion channel modulators, Metal Ion Chelators Free radical trappers, and others.

The Cholinesterase inhibitors and NMDA receptor antagonists are used to treat Alzheimers. As the disease burden is high for this ailment, these drugs would command a major market share. However, the opportunity for emerging drugs is high, as CNS disorders involve an interplay of highly complex and multi- factorial processes & pathways. Therefore, investment in research and development would have high pay offs.

Neuroprotective Products Market by use in the treatment of Medical Conditions

The neuroprotective drugs are used in the treatment of Alzheimer's disease, Multiple sclerosis, Parkinson's disease, Brain injury, Huntington's disease, Retinal disorders, Amyotrophic lateral sclerosis (ALS), Neuropathies, and other disorders affecting the nervous system.

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/262

According to the Alzheimer's association, an estimated 5.2 million Americans have Alzheimer's and it is the 6th leading cause of death accounting for the death of more than 500,000 persons per year in the United States. Hence, the market for treatment of Alzheimers is huge and it would spur the development of neuroprotective drugs.

Neuroprotective Market by Geography

The market is segmented by geography into North America, Europe, Asia Pacific and RoW. In the United States, death due to Alzheimers increased by 68 percent during 2000 to 2010. According to the Parkinson Disease foundation, 60,000 Americans are diagnosed of Parkinsons each year. Hence, North America is the major market for these products. World ‐wide, an estimated five to seven million people are living with Parkinson disease, which would increase the demand for neuroprotective drugs and spur research and development. Europe and Asia Pacific would also see an increased demand as the cases for neurodegenerative diseases increases in these regions.

High Level Analysis

An overview of the neuroprotective market by segmentation of the market by type, application and geography, identifies the opportunities as well as associated risks in this market. Porter’s five force model analyzes the bargaining power of the supplier and buyer as well as the threat posed by substitutes and new entrants which would enable a deeper understanding of changing market dynamics. The report helps to identify market leaders and the strategic business decisions taken by them. The impact of drivers, restraints and opportunities and other market dynamics are described in detail.

Key Benefits

• Competitive analysis of companies and policies adopted by competitors would help in making strategic decisions
• In-depth analysis of current market scenario would help in understanding opportunities in this market
• Segmentation based on applications would help in understanding future growth prospects and areas where investments can be made.
• Analysis of drivers and restrains focuses on the opportunities and risks of this market, which would enable decision-making
• Estimations of growth in this market based on upcoming drugs would give an overall idea of areas of growth to stakeholders.

About us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuroprotective Products Market Status and Ongoing Development Trends by Key Players: Genervon Biopharmaceuticals, NeuroVive Pharmaceutical,Ceregene, BHRPharma LLC, Neuren Pharmaceuticals and More here

News-ID: 1609462 • Views: 364

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Neuroprotective

Neuroprotective Agents Global Information 2019: Therapeutic Applications
Press Release – 29 Jan 2019 Research and Development News -- . . Latest Update "Neuroprotective Agents: Therapeutic Applications and Global Markets" with Industries Survey | Global Current Growth and Future. ' ' According to the 2007 Global Burden of Disease report from the World Health Organization (WHO), more than 1 billion people worldwide suffered from neurological disorders, including stroke, Alzheimers disease, epilepsy, Parkinsons disease (PD), brain injuries, and glaucoma and other eye disorders.
Global Neuroprotective Agents Market Projections & Therapeutic Applications Anal …
The prevalence of neurological disorders on the global level has enhanced over the past few years. It has been recorded by the World Health Organization (WHO) that more than 1 billion people on the global scale suffered from neurological disorders, such as stroke, epilepsy, Alzheimers disease, Parkinsons disease (PD), glaucoma and brain injuries. As a method to control such occurrences, the implementation of neuroprotective agents is majorly practiced as a therapeutic
Neuroprotective Agents Market 2018: Global Snapshot Analysis to 2022
OrbisResearch.com has published new research report on “Global Neuroprotective Agents Market Research Report and Forecast to 2018-2022” to its database. According to the 2007 Global Burden of Disease report from the World Health Organization (WHO), more than 1 billion people worldwide suffered from neurological disorders, including stroke, Alzheimer’s disease, epilepsy, Parkinson’s disease (PD), brain injuries, and glaucoma and other eye disorders. Nearly 7 million people died from these diseases. According to
Neuroprotective Products Market Latest Trends and Future Growth Study by 2024
Global Neuroprotective Products Market: Overview Neuroprotective products consist of medications that can be used to protect or preserve the neuronal cells of the brain from degeneration, stress, and injury, which can impair cognitive functions. These products have applications for the treatment of many central nervous system complications as stroke, spinal cord injury, neurodegenerative diseases, such as Parkinson’s disease and Alzheimer’s disease, and a range of traumatic brain injuries. The prevalence of
Neuroprotective Products Market Estimated to Experience a Hike in Growth by 2016 …
Neuroprotective products consist of medications that can be used to protect or preserve the neuronal cells of the brain from degeneration, stress, and injury, which can impair cognitive functions. These products have applications for the treatment of many central nervous system complications as stroke, spinal cord injury, neurodegenerative diseases, such as Parkinson’s disease and Alzheimer’s disease, and a range of traumatic brain injuries. The prevalence of various neurodegenerative diseases, particularly
Global Neuroprotective Products Market Research Report Offers Forecast and Analy …
To study the market for Neuroprotective Products in a precise manner, Market Research Hub (MRH) has included a new research report. The report is titled “Global Neuroprotective Products Market”, which enlightens the readers about the market share as well as growth rate during the period 2017- 2022. The research study estimates that the Healthcare sector would be rising with a positive CAGR during the same stated forecast period. Request For